Trial intelligence / Profile preview

MTAC: Tacrolimus and Mycophenolate Mofetil for Idiopathic Membranous Glomerulonephritis

NCT00843856Phase 4Completed

Sponsor
Imperial College Healthcare NHS Trust
Start
Mar 2009
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of mycophenolate mofetil in membranous glomerulonephritis (MGN), sponsored by Imperial College Healthcare NHS Trust. Started Mar 2009; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

membranous glomerulonephritis (MGN)

Beyond the preview

Go deeper on NCT00843856.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00843856.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call